Drug Development Solutions
-
AAV Production: Your AAV CDMO Partner, Every Batch, Every Milestone
6/17/2025
Confidently navigate every stage of development with tailored tech transfer solutions backed by AAV expertise. Discover how to de-risk, scale, and optimize your process for high-quality performance.
-
A CDMO With Oral Solid Dose And Sterile Injectable Expertise
6/6/2022
Societal specializes in modified-release formulations, including those for high potent and DEA controlled substances.
-
HyClone Cell Boost 2 Supplement
9/21/2020
Improve productivity and cell growth in fed-batch cultures by supplementing the cell culture medium to boost nutrients depleted during culture. HyClone™ Cell Boost™ 2 Supplement provides nutrients such as amino acids and glucose that are suitable for research and bioprocessing applications.
-
Plug Into The Future Of Bispecific Antibodies
Lonza’s bYlok® technology is a true plug-and-play solution to bispecific antibody engineering – high product quality, simplified processes, unlocking the future.
-
Customized CMC Solutions
Leverage customizable CMC solutions to address unique developmental challenges and propel your molecule toward IND filing and beyond, ensuring an efficient transition to the next stage of development.
-
A Technology-Driven CDMO Delivering Integrated End-To-End Services
Explore this interactive PDF with information about technologies & end-to-end integrated CDMO services provided by Adare Pharma Solutions.
-
Curia R&D Pipeline Overview
2/18/2026
This pipeline outlines a sequence of late‑stage and emerging therapeutics projected to launch between 2024 and 2031, spanning immunology, neurology, psychiatry, rare disease, oncology, and inflammatory disorders.
-
Accelerating FIH Trials To POC With Speed, Safety, And Certainty
10/15/2025
Overcome clinical transition challenges with integrated services, including study design, expert regulatory support, robust recruitment, and flexible manufacturing.
-
Drug Product Development And Manufacturing Services
3/17/2025
Backed by trusted data and deep scientific expertise, learn how our adaptive approach ensures seamless progression from preclinical development to commercial manufacturing.
-
Pre-Formulation And Material Sciences
3/3/2022
Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.